Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease independent of anti-thyroid drug therapy

被引:3
|
作者
Khan, Nasim Ahmed [1 ,2 ]
Singh, Manisha [3 ]
机构
[1] Univ Arkansas Med Sci, Div Rheumatol, Little Rock, AR 72205 USA
[2] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA
[3] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA
关键词
Antineutrophil cytoplasmic antibody-associated vasculitis; Antithyroid agents; Granulomatosis with polyangiitis (Wegener's); Graves' disease; WEGENERS-GRANULOMATOSIS; PROPYLTHIOURACIL; ANCA; HYPERTHYROIDISM; MANIFESTATIONS; PATHOGENESIS; AUTOANTIBODIES; PREVALENCE; FREQUENCY; BINDING;
D O I
10.1007/s10165-011-0570-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) in patients with Graves' disease (GD) is linked with the use of anti-thyroid drugs (ATDs). We report the co-occurrence of AAV and GD in a patient that was independent of ATD therapy. A 38-year-old white male presented with systemic symptoms, palpitations, tremors, purpuric skin lesions, and digital pain. Physical examination and biological tests confirmed GD. He quickly developed multiple digital gangrenes and testicular pain/mass. Skin and testicular biopsies showed granulomatous vasculitis of the small- and medium-sized vessels, while his serum contained anti-proteinase-3 antibody.
引用
收藏
页码:778 / 782
页数:5
相关论文
共 50 条
  • [1] Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014
    Schoenermarck, Ulf
    Csernok, Elena
    Gross, Wolfgang L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i46 - i52
  • [2] Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes
    Shi, Lei
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (11) : 1779 - 1788
  • [3] Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Hruskova, Zdenka
    Geetha, Duvuru
    Tesar, Vladimir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i159 - i163
  • [4] Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Sun, Xiao-Jing
    Li, Zhi-Ying
    Chen, Min
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2023, 4 (01): : 11 - 21
  • [5] Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Gan, Poh-Yi
    Ooi, Joshua D.
    Kitching, A. Richard
    Holdsworth, Stephen R.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (18) : 2380 - 2390
  • [6] Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
    Weng, Cheng-Hua
    Liu, Zhi-Chun
    CHINESE MEDICAL JOURNAL, 2019, 132 (23) : 2848 - 2855
  • [7] Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Alberici, Federico
    Martorana, Davide
    Vaglio, Augusto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i37 - i45
  • [8] Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Rhee, Eugene P.
    Laliberte, Karen A.
    Niles, John L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (08): : 1394 - 1400
  • [9] Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes
    Lei Shi
    Rheumatology International, 2017, 37 : 1779 - 1788
  • [10] AN OVERVIEW OF PHARMACOTHERAPY FOR ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Stasi, R.
    DRUGS OF TODAY, 2010, 46 (12) : 919 - 928